D. E. Shaw & Co., Inc. Galapagos Nv Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Galapagos Nv stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 51,673 shares of GLPG stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,673

Previous 75,640 31.69%

Holding current value

$1.3 Million

Previous $3.07 Million 45.9%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.2 - $42.44 $771,737 - $1.02 Million	-23,967 Reduced 31.69%	51,673 $1.66 Million
Q4 2023 Feb 14, 2024	BUY	$31.87 - $40.71 $583,061 - $744,789	18,295 Added 31.9%	75,640 $3.07 Million
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $1.39 Million - $1.75 Million	40,798 Added 246.56%	57,345 $1.98 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $618,857 - $736,672	16,547 New	16,547 $672,000
Q4 2022 Feb 14, 2023	SELL	$37.44 - $46.51 $2.48 Million - $3.08 Million	-66,138 Reduced 52.43%	59,996 $2.66 Million

Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $228,722 - $311,673	5,411 Added 4.48%	126,134 $5.38 Million
Q2 2022 Aug 15, 2022	BUY	$52.3 - $71.59 $4.05 Million - $5.55 Million	77,508 Added 179.35%	120,723 $6.74 Million
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $4.83 Million - $6.45 Million	-94,125 Reduced 68.53%	43,215 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $25,349 - $30,787	539 Added 0.39%	137,340 $7.57 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $3.64 Million - $4.89 Million	69,710 Added 103.9%	136,801 $7.2 Million
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $4.32 Million - $5.23 Million	62,719 Added 1434.56%	67,091 $4.62 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $332,927 - $489,401	4,372 New	4,372 $337,000
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $905,353 - $1.39 Million	-9,348 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$122.47 - $213.56 $507,148 - $884,351	4,141 Added 79.53%	9,348 $1.33 Million
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $160,660 - $200,262	-866 Reduced 14.26%	5,207 $1.03 Million
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $339,339 - $650,273	2,373 Added 64.14%	6,073 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $540,644 - $798,534	3,700 New	3,700 $765,000
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $418,451 - $601,949	-3,208 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $2.19 Million - $2.54 Million	-19,691 Reduced 85.99%	3,208 $414,000
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $341,055 - $448,270	3,806 Added 19.93%	22,899 $2.7 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $1.31 Million - $1.65 Million	14,893 Added 354.6%	19,093 $1.75 Million
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $380,646 - $504,924	4,200 New	4,200 $472,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

16.5M

Call Options Held

77.1K

Put Options Held

57.2K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.65B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account